慢性冠状动脉完全闭塞病变介入治疗并发症风险评估进展

孟利民; 谷国强

doi:10.13201/j.issn.1001-1439.2021.11.002

慢性冠状动脉完全闭塞病变介入治疗并发症风险评估进展

孟利民¹,
谷国强^2, ,

- 1. 邯郸市第一医院心内科(河北邯郸, 056002);
- 2. 河北医科大学第二医院心内科
基金项目:
河北省自然科学基金精准医学联合基金重点项目(No:H2020206409)

详细信息

通讯作者: 谷国强,E-mail:guguoqiang21@163.com

中图分类号: R541.4

收稿日期: 2021-04-15

Advances in risk assessment of complications of chronic total occlusion percutaneous coronary intervention

MENG Limin¹,
GU Guoqiang^2, ,

- 1. Department of Cardiology, Handan First Hospital, Hebei, 056002, China;
- 2. Department of Cardiology, the Second Hospital of Hebei Medical University

More Information

Corresponding author: GU Guoqiang, E-mail: guguoqiang21@163.com

Received Date: 15 April 2021

摘要

摘要: 慢性冠状动脉完全闭塞病变的介入治疗(CTO-PCI)尽管临床有益,但手术并发症发生率明显高于非完全闭塞病变,影响患者预后。识别潜在的并发症风险,最大限度地降低并发症的发生,并及时地进行治疗尤为重要。本文回顾了CTO-PCI并发症风险评估的相关研究,并概述了避免并发症的策略,旨在及时准确识别CTO-PCI围手术期并发症相关的不良预后指标。
- 慢性完全闭塞病变 /
- 经皮冠状动脉介入治疗 /
- 并发症 /
- 风险评估
Abstract: Despite its clinical benefits, chronic total occlusion(CTO) percutaneous coronary intervention(PCI) is associated with higher complication rates, which affects the prognosis of patients. It is particularly important to identity the potential complications, minimize the risk of complications and allow prompt treatment should they occur. This paper reviews the relevant studies on the risk assessment of complications of CTO-PCI and outlines strategies to avoid complications, for identifying the adverse prognostic indicators timely and accurately.
- chronic total occlusion /
- percutaneous coronary intervention /
- complications /
- risk assessment

HTML全文

参考文献(32)

[1]	Ybarra LF,Rinfret S.Why and how should we treat chronic total occlusion?evolution of state-of-the-art methods and future directions[J].Can J Cardiol,2020,10(17):S0828-282X(20)31052-7.
[2]	Schumacher SP,Driessen RS,Stuijfzand WJ,et al.Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions[J].Catheter Cardiovasc Interv,2019,93(6):1059-1066.
[3]	李小波,高晓飞,邵明学,等.血管内超声与冠状动脉造影引导药物洗脱支架植入治疗慢性完全闭塞性病变:5年随访结果[J].临床心血管病杂志,2020,36(7):604-607.
[4]	Xenogiannis I,Nikolakopoulos I,Krestyaninov O,et al.Impact of successful chronic total occlusion percutaneous coronary interventions on subsequent clinical outcomes[J].J Invasive Cardiol,2020,32(11):433-439.
[5]	Karacsonyi J,Vemmou E,Nikolakopoulos ID,et al.Complications of chronic total occlusion percutaneous coronary intervention[J].Neth Heart J,2021,29(1):60-67.
[6]	戴士鹏,柳永青,曹程,等.逆向开通慢性完全闭塞病变介入治疗过程中侧支通道穿孔的治疗及预后[J].临床心血管病杂志,2019,35(6):509-512.
[7]	Su YM,Pan M,Geng HH,et al.Outcomes after percutaneous coronary intervention and comparison among scoring systems in predicting procedural success in elderly patients(≥ 75 years)with chronic total occlusion[J].Coron Artery Dis,2019,30(7):481-487.
[8]	Tajti P,Karmpaliotis D,Alaswad K,et al.The hybrid approach to chronic total occlusion percutaneous coronary intervention:update from the PROGRESS CTO registry[J].JACC Cardiovasc Interv,2018,11(14):1325-1335.
[9]	André R,Dumonteil N,Lhermusier T,et al.In-hospital and long-term outcomes after percutaneous coronary intervention for chronic total occlusion in elderly patients:A consecutive,prospective,single-centre study[J].Arch Cardiovasc Dis,2016,109(1):13-21.
[10]	Lateef N,Ahsan MJ,Fazeel HM,et al.Percutaneous coronary intervention for chronic total occlusion in patients aged<75 years versus ≥75 years:a systematic review[J].J Community Hosp Intern Med Perspect,2020,10(1):25-31.
[11]	Hirai T,Nicholson WJ,Sapontis J,et al.A detailed analysis of perforations during chronic total occlusion angioplasty[J].JACC Cardiovasc Interv,2019,12(19):1902-1912.
[12]	Danek BA,Karatasakis A,Tajti P,et al.Incidence,treatment,and outcomes of coronary perforation during chronic total occlusion percutaneous coronary intervention[J].Am J Cardiol,2017,120(8):1285-1292.
[13]	Wan J,Wang P,Zhou P,et al.Predictors and management of antiplatelet-related bleeding complications for acute coronary syndrome in chinese elderly patients[J].Cell Physiol Biochem,2018,50(3):1164-1177.
[14]	Galassi AR,Boukhris M,Toma A,et al.Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction[J].JACC Cardiovasc Interv,2017,10(21):2158-2170.
[15]	Goliasch G,Winter MP,Ayoub M,et al.A contemporary definition of periprocedural myocardial injury after percutaneous coronary intervention of chronic total occlusions[J].JACC Cardiovasc Interv,2019,12(19):1915-1923.
[16]	Aktürk E,Aşkın L,Taşolar H,et al.Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions[J].Interv Med Appl Sci,2019,11(2):95-100.
[17]	König S,Boudriot E,Arya A,et al.Incidence and characteristics of ventricular tachycardia in patients after percutaneous coronary revascularization of chronic total occlusions[J].PLoS One,2019,14(11):e0225580.
[18]	Tajti P,Karmpaliotis D,Alaswad K,et al.Prevalence,Presentation and treatment of balloon undilatable chronic total occlusions:insights from a multicenter US registry[J].Catheter Cardiovasc Interv,2018,91(4):657-666.
[19]	Megaly M,Abraham B,Pershad A,et al.Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery[J].JACC Cardiovasc Interv,2020,13(7):900-902.
[20]	Tajti P,Karmpaliotis D,Alaswad K,et al.In-Hospital outcomes of chronic total occlusion percutaneous coronary interventions in patients with prior coronary artery bypass graft surgery[J].Circ Cardiovasc Interv,2019,12(3):e007338.
[21]	Tajti P,Karatasakis A,Danek BA,et al.In-Hospital outcomes of chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease[J].J Invasive Cardiol,2018,30(11):E113-E121.
[22]	Malik AO,Spertus JA,Grantham JA,et al.Outcomes of chronic total occlusion percutaneous coronary intervention in patients with renal dysfunction[J].Am J Cardiol,2020,125(7):1046-1053.
[23]	Kim CH,Yang JH,Park TK,et al.Revascularization vs.medical therapy for coronary chronic total occlusions in patients with chronic kidney disease[J].Circ J,2018,82(8):2136-2142.
[24]	Azzalini L,Ojeda S,Demir OM,et al.Recanalization of chronic total occlusions in patients with vs without chronic kidney disease:The impact of contrast-induced acute kidney injury[J].Can J Cardiol,2018,34(10):1275-1282.
[25]	Danek BA,Karatasakis A,Karmpaliotis D,et al.Development and validation of a scoring system for predicting periprocedural complications during percutaneous coronary interventions of chronic total occlusions:the prospective global registry for the study of chronic total occlusion intervention(PROGRESS CTO)complications score[J].J Am Heart Assoc,2016,5(10):e004272.
[26]	Tian T,Guan C,Gao L,et al.Prognostic significance of occlusion length in recanalized chronic total occlusion lesion:a retrospective cohort study with 5-year follow-up[J].BMJ Open,2020,10(7):e038302.
[27]	Ahn J,Rha SW,Choi B,et al.Impact of chronic total occlusion lesion length on six-month angiographic and 2-year clinical outcomes[J].PLoS One,2018,13(11):e0198571.
[28]	Bryniarski KL,Werner GS,Mashayekhi K,et al.Differences in patients and lesion and procedure characteristics depending on the age of the coronary chronic total occlusion[J].Postepy Kardiol Interwencyjnej,2019,15(1):28-41.
[29]	Karacsonyi J,Karmpaliotis D,Alaswad K,et al.Impact of calcium on chronic total occlusion percutaneous coronary interventions[J].Am J Cardiol,2017,120(1):40-46.
[30]	Megaly M,Ali A,Saad M,et al.Outcomes with retrograde versus antegrade chronic total occlusion revascularization[J].Catheter Cardiovasc Interv,2020,96(5):1037-1043.
[31]	Zein R,Seth M,Othman H,et al.Association of operator and hospital experience with procedural success rates and outcomes in patients undergoing percutaneous coronary interventions for chronic total occlusions:insights from the blue cross blue shield of michigan cardiovascular consortium[J].Circ Cardiovasc Interv,2020,13(8):e008863.
[32]	Christakopoulos GE,Christopoulos G,Karmpaliotis D,et al.Predictors of excess patient radiation exposure during chronic total occlusion coronary intervention:insights from a contemporary multicentre registry[J].Can J Cardiol,2017,33(4):478-484.